BioCentury | Jan 10, 2020
Emerging Company Profile

Empirica: Building a new model for brain cancer

Empirica is developing antibody-based therapies for glioblastoma multiforme using a mouse model built to mimic the biology of recurrent brain cancer, rather than that of primary tumors. Its lead candidate is a CAR T cell...
Items per page:
1 - 1 of 1